Cargando…

Efficacy of lenalidomide in association with cyclophosphamide and dexamethasone in multiple myeloma patient with bilateral retro-orbital localisation

Extramedullary localisation is an uncommon manifestation in multiple myeloma (MM). Ocular involvement is rare. Here, we describe a relapse of MM with bilateral retro-orbital localisation without any bone involvement with good and rapid response to therapy with lenalidomide, dexamethasone, and cyclop...

Descripción completa

Detalles Bibliográficos
Autores principales: Felici, S, Villivà, N, Balsamo, G, Andriani, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3965188/
https://www.ncbi.nlm.nih.gov/pubmed/24723969
http://dx.doi.org/10.3332/ecancer.2013.331
_version_ 1782479307091738624
author Felici, S
Villivà, N
Balsamo, G
Andriani, A
author_facet Felici, S
Villivà, N
Balsamo, G
Andriani, A
author_sort Felici, S
collection PubMed
description Extramedullary localisation is an uncommon manifestation in multiple myeloma (MM). Ocular involvement is rare. Here, we describe a relapse of MM with bilateral retro-orbital localisation without any bone involvement with good and rapid response to therapy with lenalidomide, dexamethasone, and cyclophosphamide.
format Online
Article
Text
id pubmed-3965188
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Cancer Intelligence
record_format MEDLINE/PubMed
spelling pubmed-39651882014-04-10 Efficacy of lenalidomide in association with cyclophosphamide and dexamethasone in multiple myeloma patient with bilateral retro-orbital localisation Felici, S Villivà, N Balsamo, G Andriani, A Ecancermedicalscience Case Report Extramedullary localisation is an uncommon manifestation in multiple myeloma (MM). Ocular involvement is rare. Here, we describe a relapse of MM with bilateral retro-orbital localisation without any bone involvement with good and rapid response to therapy with lenalidomide, dexamethasone, and cyclophosphamide. Cancer Intelligence 2013-07-10 /pmc/articles/PMC3965188/ /pubmed/24723969 http://dx.doi.org/10.3332/ecancer.2013.331 Text en © the authors; licensee ecancermedicalscience. http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Felici, S
Villivà, N
Balsamo, G
Andriani, A
Efficacy of lenalidomide in association with cyclophosphamide and dexamethasone in multiple myeloma patient with bilateral retro-orbital localisation
title Efficacy of lenalidomide in association with cyclophosphamide and dexamethasone in multiple myeloma patient with bilateral retro-orbital localisation
title_full Efficacy of lenalidomide in association with cyclophosphamide and dexamethasone in multiple myeloma patient with bilateral retro-orbital localisation
title_fullStr Efficacy of lenalidomide in association with cyclophosphamide and dexamethasone in multiple myeloma patient with bilateral retro-orbital localisation
title_full_unstemmed Efficacy of lenalidomide in association with cyclophosphamide and dexamethasone in multiple myeloma patient with bilateral retro-orbital localisation
title_short Efficacy of lenalidomide in association with cyclophosphamide and dexamethasone in multiple myeloma patient with bilateral retro-orbital localisation
title_sort efficacy of lenalidomide in association with cyclophosphamide and dexamethasone in multiple myeloma patient with bilateral retro-orbital localisation
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3965188/
https://www.ncbi.nlm.nih.gov/pubmed/24723969
http://dx.doi.org/10.3332/ecancer.2013.331
work_keys_str_mv AT felicis efficacyoflenalidomideinassociationwithcyclophosphamideanddexamethasoneinmultiplemyelomapatientwithbilateralretroorbitallocalisation
AT villivan efficacyoflenalidomideinassociationwithcyclophosphamideanddexamethasoneinmultiplemyelomapatientwithbilateralretroorbitallocalisation
AT balsamog efficacyoflenalidomideinassociationwithcyclophosphamideanddexamethasoneinmultiplemyelomapatientwithbilateralretroorbitallocalisation
AT andriania efficacyoflenalidomideinassociationwithcyclophosphamideanddexamethasoneinmultiplemyelomapatientwithbilateralretroorbitallocalisation